Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
[41]   Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care? [J].
Gongora, Carlos A. ;
Zhang, Lili ;
Mattei, Juan Lopez ;
Ruiz-Mori, Enrique ;
Gonzalez-Robledo, Gina ;
Slipczuk, Leandro ;
Lara, Joffre ;
Cossio-Aranda, Jorge E. ;
Badimon, Juan .
CARDIOVASCULAR DRUGS AND THERAPY, 2025, 39 (04) :849-856
[42]   Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Malnutrition, Frailty, Sarcopenia, or Cachexia [J].
Horiuchi, Yu ;
Asami, Masahiko ;
Yahagi, Kazuyuki ;
Oshima, Asahi ;
Gonda, Yuki ;
Yoshiura, Daiki ;
Komiyama, Kota ;
Yuzawa, Hitomi ;
Tanaka, Jun ;
Aoki, Jiro ;
Tanabe, Kengo .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
[43]   Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease [J].
Zhou, Tianbiao ;
Yao, Kaijin ;
Xie, Yina ;
Lin, Yongda ;
Wang, Jiali ;
Chen, Xiutian .
CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (21) :1659-1670
[44]   Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure A Systematic Review and Meta-analysis [J].
Zou, Xinyu ;
Shi, Qingyang ;
Vandvik, Per Olav ;
Guyatt, Gordon ;
Lang, Chim C. ;
Parpia, Sameer ;
Wang, Si ;
Agarwal, Arnav ;
Zhou, Yiling ;
Zhu, Ye ;
Tian, Haoming ;
Zhu, Zhiming ;
Li, Sheyu .
ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) :851-+
[45]   A new era of diabetic kidney disease treatment with sodium-glucose cotransporter-2 inhibitors [J].
Kume, Shinji ;
Maegawa, Hiroshi .
JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (05) :765-767
[46]   Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors as a Dual Therapeutic Target for Cardiovascular and Renal Health: A Narrative Review [J].
Al Rashid, Sulthan ;
Madar, Inamul Hasan ;
Misbah, Iffath ;
Dhanabalan, Kamalakannan ;
Balasubramanian, Rajkapoor ;
Maideen, Naina Mohamed Pakkir .
IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2025, 17 (01) :4-12
[47]   A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes [J].
Yoshida, Yilin ;
Cheng, Xi ;
Shao, Hui ;
Fonseca, Vivian A. ;
Shi, Lizheng .
CURRENT DIABETES REPORTS, 2020, 20 (04)
[48]   Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients [J].
Sata, Suchita Shah ;
Spratt, Susan E. ;
Edmonston, Daniel L. ;
Pagidipati, Neha .
JOURNAL OF HOSPITAL MEDICINE, 2022, 17 (05) :360-363
[49]   Patients With Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors Undergoing Total Knee Arthroplasty Are at Increased Odds for a Number of Postoperative Adverse Events But Reduced Risk of Transfusion [J].
Kim, Lucas Y. ;
Wiznia, Daniel H. ;
Grauer, Jonathan N. .
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2025, 33 (15) :856-862
[50]   The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study [J].
Steinmetz, Tali ;
Goldman, Shira ;
Kagan, Kim Ben Tikva ;
Bielopolski, Dana ;
Buchrits, Shira ;
Schechter, Amir ;
Kushnir, Shiri ;
Turjeman, Adi ;
Agur, Timna ;
Grossman, Alon ;
Gvili, Anat Gafter ;
Zvi, Benaya Rozen .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
12345